These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Insulin secretion and action in different stages of glucose tolerance in Asian Indians. Snehalatha C, Satyavani K, Sivasankari S, Vijay V, Ramachandran A. Diabet Med; 1999 May; 16(5):408-14. PubMed ID: 10342341 [Abstract] [Full Text] [Related]
43. Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids. Mingrone G, DeGaetano A, Greco AV, Capristo E, Benedetti G, Castagneto M, Gasbarrini G. Diabetologia; 1997 May; 40(5):599-605. PubMed ID: 9165230 [Abstract] [Full Text] [Related]
44. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study. Bianchi C, Miccoli R, Trombetta M, Giorgino F, Frontoni S, Faloia E, Marchesini G, Dolci MA, Cavalot F, Cavallo G, Leonetti F, Bonadonna RC, Del Prato S, GENFIEV Investigators. J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736 [Abstract] [Full Text] [Related]
48. Comparison of changes in blood glucose, insulin resistance indices, and adipokine levels in diabetic and nondiabetic subjects with morbid obesity after laparoscopic adjustable gastric banding. Urbanavičius V, Abalikšta T, Brimas G, Abraitienė A, Gogelienė L, Strupas K. Medicina (Kaunas); 2013 May; 49(1):9-14. PubMed ID: 23652711 [Abstract] [Full Text] [Related]
49. Insulin sensitivity and first-phase insulin secretion in obese Chinese with hyperglycemia in 30 and/or 60 min during glucose tolerance tests. Hong J, Zhang YF, Gu WQ, Zhang YW, Su YX, Chi ZN, Wang WQ, Li XY, Ning G. Endocrine; 2008 May; 34(1-3):75-80. PubMed ID: 18979203 [Abstract] [Full Text] [Related]
50. Postprandial oscillatory patterns of blood glucose and insulin in NIDDM. Abnormal diurnal insulin secretion patterns and glucose homeostasis independent of obesity. Calles-Escandon J, Jaspan J, Robbins DC. Diabetes Care; 1989 May; 12(10):709-14. PubMed ID: 2693010 [Abstract] [Full Text] [Related]
53. Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function. Mari A, Manco M, Guidone C, Nanni G, Castagneto M, Mingrone G, Ferrannini E. Diabetologia; 2006 Sep; 49(9):2136-43. PubMed ID: 16819611 [Abstract] [Full Text] [Related]
54. Acute and chronic effects of dexfenfluramine on glucose and insulin response to intravenous glucose in diabetic and non-diabetic obese subjects. Glaser B, Raveh Y, Norynberg C, Berry E, Lavielle R, Nathan C, Cerasi E. Diabetes Res; 1992 Sep; 19(4):165-76. PubMed ID: 1343113 [Abstract] [Full Text] [Related]
58. Insulin release and peripheral sensitivity at the oral glucose tolerance test. Cederholm J, Wibell L. Diabetes Res Clin Pract; 1990 Oct; 10(2):167-75. PubMed ID: 2261853 [Abstract] [Full Text] [Related]
59. Beta-cell function and mass in type 2 diabetes. Larsen MO. Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971 [Abstract] [Full Text] [Related]
60. Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Pettiti M, Natali A, Mari A, DeFronzo RA. Diabetologia; 2003 Sep; 46(9):1211-9. PubMed ID: 12879253 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]